Minirin 0.2mg Tablet

Minirin 0.2mg Tablet contains an active component as Desmopressin. It also known as DDAVP (1-desamino-8-D-arginine vasopressin), is a synthetic form of the hormone vasopressin. Vasopressin is naturally produced in the body by the hypothalamus and released from the pituitary gland. It plays a crucial role in regulating water balance, blood pressure, and urine production.  Minirin 0.2mg Tablet is the treatment of choice for central diabetes insipidus, a condition characterized by the inability of the body to properly regulate water balance. It helps reduce excessive thirst and urination by mimicking the action of vasopressin. It is sometimes used in the treatment of mild to moderate forms of VWD, a bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor. It stimulates the release of von Willebrand factor, which aids in clotting.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Minirin 0.2mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Minirin 0.2mg Tablet is a hormone analogue that treats diabetes insipidus, post-hypophysectomy polyuria (extreme urination) or polydipsia (excessive thirst), and bedwetting. It contains Desmopressin, a synthetic form of Vasopressin (antidiuretic hormone), which mimics the natural hormone vasopressin and works by limiting the amount of water eliminated in the urine, thus controlling excessive thirst and urination in diabetes insipidus. It also decreases the amount of urine produced, thereby preventing the urinary bladder from filling up at night time and controlling bedwetting in children. Being an anti-haemophilic agent, Minirin 0.2mg Tablet also reduces the bleeding tendency in haemophilia (bleeding disorder) by promoting the release of blood clotting factors.

Store between 20°C to 25°C

30 TABLET* 1 BOTTLE